DSM bolsters lactase portfolio with new 'one-stop-shop', super-efficient enzyme for regular and organic lactose-free dairy products

摘要

Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, has announced the launch of its new Maxilact® Super lactase enzyme. Advancing DSM's leading portfolio of Maxilact® lactases, Maxilact® Super enables dairy manufacturers to create high-quality, clean-tasting lactose-free and sugar-reduced dairy, while also helping to cut hydrolysis time by 33% and achieve optimal production efficiency. Moreover, Maxilact® Super is suitable for all dairy product positionings, from regular to organic and Verband Lebensmittel Ohne Gentechnik (VLOG). With this new enzyme innovation, lactose-free dairy producers can deliver the authenticity, health appeal and sensory experience consumers expect in all applications, without adding complexity to the production process.